CGP 35348

Known as: CGP-35348, Phosphinic acid, (3-aminopropyl)(diethoxymethyl)- 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2008
Highly Cited
2008
Treatment for schistosomiasis, which is responsible for more than 280,000 deaths annually, depends almost exclusively on… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2003
Highly Cited
2003
BACKGROUND AND OBJECTIVES The aim of this study was to determine whether Hoechst effluxing side population cells isolated from… (More)
Is this relevant?
1996
1996
Slow IPSPs, which are believed to be involved in generation of the wave of spike-wave epileptiform discharges, are mediated by… (More)
Is this relevant?
1993
1993
This study examined the potency and selectivity of the GABAB receptor antagonist CGP 35348 (3-amino-propyl(diethoxy-methyl… (More)
Is this relevant?
Highly Cited
1993
Highly Cited
1993
1. Tight-seal, whole-cell voltage clamp recording techniques were used to characterize monosynaptically evoked GABAB currents in… (More)
Is this relevant?
1992
1992
The effect of the GABAB receptor blocker CGP 35348 on epileptic processes in vitro and in vivo was studied. In hippocampal slices… (More)
Is this relevant?
1992
1992
The effect of the GABAA antagonists, bicuculline and picrotoxin, in the hot plate and writhing tests in mice and the paw-pressure… (More)
Is this relevant?
1991
1991
The effects of the new GABAB antagonist, CGP 35348 (3-aminopropane-diethoxymethylphosphinic acid), on rat striatal dopamine… (More)
  • table 1
  • figure 1
  • figure 3
  • figure 2
  • figure 4
Is this relevant?
1991
1991
1. CGP 35348, a new GABAB antagonist, was examined on antinociception induced by (+/-)-baclofen by use of the hot plate and… (More)
Is this relevant?
Highly Cited
1990
Highly Cited
1990
The biochemical, electrophysiological and pharmacological properties of the new GABAB receptor blocker CGP 35348 are described… (More)
Is this relevant?